BibTex RIS Cite

Ergenlik çağında kanserler

Year 2011, , - , 01.03.2011
https://doi.org/10.4274/tpa.46.38

Abstract

Son 30 40 yılda çocuk kanserlerinde büyük aşamalar kaydedilmiş ve çok yüksek sağkalım oranlarına ulaşılmıştır Ergenlik döneminde görülen nbsp; kanserlerin kendine has özellikleri vardır Bu dönemde görülen kanser tipleri farklı olduğu gibi elde edilen sağkalım oranları da farklıdır Bunda ergenin fiziksel yapısı kadar psikolojik etmenler de rol oynamaktadır Çocukluk yaşına göre daha çok sayıda ergen kanser tanısı almaktadır Ergende lösemi ve sarkomların iyileşme oranları çocuklara göre daha düşüktür Bu yaş grubunda Hodgkin hastalığı ve kemik tümörleri de daha sık gözlenmektedir Ergene konusunda deneyimli psikolojik destek ve eğitim sağlayacak bir ekibin tedavisi başarıyı artırmaktadır Türk Ped Arş 2011; 46 Özel Sayı: 68 9

References

  • Reaman GH, Bleyer WA. Infants and adolescents with cancer. In; Pizzo PA, Poplack DG ed (s). Principles and Practice of Pediatric oncology. 5th ed. Philadelphia: Lippincott Williams Wilkins, 2006: 452-75.
  • Bleyer WA, Viny A, Barr R. Cancer in 15 to 29 year-olds by primary site. Oncologist 2006; 11: 590-601. (Full Text)
  • Kutluk T, Yeşilipek A. On behalf of Turkish Pediatric Oncology Group (TPOG) and Turkish Pediatric Hematology Society (TPHD). Turkish National Pediatric Cancer Registry 2002-2008. 41st Congress of SIOP (International Society for Pediatric Oncology). 5-9 October 2009, Sao Paulo, Brazil. Pediatric Blood and Cancer 2009; 851.
  • Smith MA, Gurney JG, Ries LAG. Cancer among adolescents 15-19 years old. In: Ries LAG ed. Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995. NCI, SEER Program NIH Pub No 99-4649 Bethesda MD, 1999.
  • Stiller C. Epidemiology of cancer in adolescents. Med Pediatr Oncol 2002; 3: 149-55.
  • Bleyer WA. Cancer in older adolescents and young adults: epidemiology, diagnosis, treatment, survival and importance of clinical trials. Med Pediatr Oncol 2002; 38: 1-10. (Abstract) / (PDF) Şekil 2.
  • ABD istatistiksel verileri Hodgkin’s 16,1% Other 11,6% Eving’s 2,3% AML 4,2% ALL 6,4% Osteosarcoma 4,6%
  • Non-RMS sarcoma 5,9%

Malignancies in adolescence

Year 2011, , - , 01.03.2011
https://doi.org/10.4274/tpa.46.38

Abstract

Great progresses were achieved in chilhood cancers in the last 30 40 years and high survival rates are obtained Cancer in adolescents have special features and survival rates This is because of adolescent rsquo;s physical status and psychological needs More adolescents are diagnoseed with cancer in comparison to children The overall survival and cure rates of leukemias and sarcomas in the adolescent period are much lower than childhood Hodgkin rsquo;s disease and bone tumors are more frequent in adolescents Success in the treatment of adolescent cancers will increase with the treatment of these cases in specialised centers with good medical psychologic and educative staff Turk Arch Ped nbsp; 2011; 46 Suppl: 68 9

References

  • Reaman GH, Bleyer WA. Infants and adolescents with cancer. In; Pizzo PA, Poplack DG ed (s). Principles and Practice of Pediatric oncology. 5th ed. Philadelphia: Lippincott Williams Wilkins, 2006: 452-75.
  • Bleyer WA, Viny A, Barr R. Cancer in 15 to 29 year-olds by primary site. Oncologist 2006; 11: 590-601. (Full Text)
  • Kutluk T, Yeşilipek A. On behalf of Turkish Pediatric Oncology Group (TPOG) and Turkish Pediatric Hematology Society (TPHD). Turkish National Pediatric Cancer Registry 2002-2008. 41st Congress of SIOP (International Society for Pediatric Oncology). 5-9 October 2009, Sao Paulo, Brazil. Pediatric Blood and Cancer 2009; 851.
  • Smith MA, Gurney JG, Ries LAG. Cancer among adolescents 15-19 years old. In: Ries LAG ed. Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995. NCI, SEER Program NIH Pub No 99-4649 Bethesda MD, 1999.
  • Stiller C. Epidemiology of cancer in adolescents. Med Pediatr Oncol 2002; 3: 149-55.
  • Bleyer WA. Cancer in older adolescents and young adults: epidemiology, diagnosis, treatment, survival and importance of clinical trials. Med Pediatr Oncol 2002; 38: 1-10. (Abstract) / (PDF) Şekil 2.
  • ABD istatistiksel verileri Hodgkin’s 16,1% Other 11,6% Eving’s 2,3% AML 4,2% ALL 6,4% Osteosarcoma 4,6%
  • Non-RMS sarcoma 5,9%
There are 8 citations in total.

Details

Primary Language Turkish
Journal Section Review
Authors

İnci Yıldız This is me

Publication Date March 1, 2011
Published in Issue Year 2011

Cite

APA Yıldız, İ. (2011). Ergenlik çağında kanserler. Türk Pediatri Arşivi, 46(11). https://doi.org/10.4274/tpa.46.38
AMA Yıldız İ. Ergenlik çağında kanserler. Türk Pediatri Arşivi. March 2011;46(11). doi:10.4274/tpa.46.38
Chicago Yıldız, İnci. “Ergenlik çağında Kanserler”. Türk Pediatri Arşivi 46, no. 11 (March 2011). https://doi.org/10.4274/tpa.46.38.
EndNote Yıldız İ (March 1, 2011) Ergenlik çağında kanserler. Türk Pediatri Arşivi 46 11
IEEE İ. Yıldız, “Ergenlik çağında kanserler”, Türk Pediatri Arşivi, vol. 46, no. 11, 2011, doi: 10.4274/tpa.46.38.
ISNAD Yıldız, İnci. “Ergenlik çağında Kanserler”. Türk Pediatri Arşivi 46/11 (March 2011). https://doi.org/10.4274/tpa.46.38.
JAMA Yıldız İ. Ergenlik çağında kanserler. Türk Pediatri Arşivi. 2011;46. doi:10.4274/tpa.46.38.
MLA Yıldız, İnci. “Ergenlik çağında Kanserler”. Türk Pediatri Arşivi, vol. 46, no. 11, 2011, doi:10.4274/tpa.46.38.
Vancouver Yıldız İ. Ergenlik çağında kanserler. Türk Pediatri Arşivi. 2011;46(11).